"Cardiac Output, Low" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Descriptor ID |
D002303
|
MeSH Number(s) |
C14.280.148 C23.888.192
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cardiac Output, Low".
Below are MeSH descriptors whose meaning is more specific than "Cardiac Output, Low".
This graph shows the total number of publications written about "Cardiac Output, Low" by people in this website by year, and whether "Cardiac Output, Low" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2012 | 1 | 0 | 1 |
2017 | 5 | 1 | 6 |
2018 | 3 | 3 | 6 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiac Output, Low" by people in Profiles.
-
Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2. Eur Heart J. 2020 Oct 14; 41(39):3863-3864.
-
Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes. J Am Heart Assoc. 2019 07 02; 8(13):e013032.
-
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 02 07; 380(6):539-548.
-
Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Crit Care. 2018 08 17; 22(1):193.
-
Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2018 05; 105(5):1403-1410.
-
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Am Heart J. 2018 04; 198:145-151.
-
Levosimendan for Perioperative Cardioprotection: Myth or Reality? Curr Cardiol Rev. 2018; 14(3):142-152.
-
Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Can J Cardiol. 2018 01; 34(1):16-22.
-
Incidence and Predictors of Postoperative Need for High-Dose Inotropic Support in Patients Undergoing Cardiac Surgery for Infective Endocarditis. J Cardiothorac Vasc Anesth. 2018 12; 32(6):2528-2536.
-
Impaired maternal hemodynamics in morbidly obese women: a case-control study. Ultrasound Obstet Gynecol. 2017 Dec; 50(6):761-765.